[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-345749-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-345749-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-oncogenic-and-tumor-suppressive-roles-of-snhg18-a-double-edged-long-noncoding-rna-in-cancer","The Oncogenic and Tumor-Suppressive Roles of SNHG18: A Double-Edged Long Noncoding RNA in Cancer","","Long noncoding RNAs (lncRNAs) contribute to the development of diverse cancers, and small nucleolar RNA host gene 18 (SNHG18) is highlighted as a dual-function lncRNA in the SNHG family. SNHG18 shows dysregulated expression across tumors, behaving as either oncogenic or tumor-suppressive depending on the cancer context. Evidence indicates cancer-type specific regulation, with upregulation in glioma, multiple myeloma, and lung cancer, and downregulation in bladder and hepatocellular cancer. Clinical findings also associate SNHG18 with prognosis. The survey reviews SNHG18 biological functions and evaluates its potential as a biomarker for diagnosis and therapy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-oncogenic-and-tumor-suppressive-roles-of-snhg18-a-double-edged-long-noncoding-rna-in-cancer/345749/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-oncogenic-and-tumor-suppressive-roles-of-snhg18-a-double-edged-long-noncoding-rna-in-cancer/345749.png","ImageObject",300,407,{"name":42,"@type":43},"Sage","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-11","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does SNHG18 play in cancer?","Question",{"text":63,"@type":64},"SNHG18 acts as a dual-edge lncRNA, functioning as either an oncogene or a tumor suppressor depending on the cancer context.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is SNHG18 expression different across cancer types?",{"text":68,"@type":64},"SNHG18 is upregulated in glioma, multiple myeloma, and lung cancer, while it is downregulated in bladder and hepatocellular cancer.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is SNHG18 considered important for clinical use?",{"text":72,"@type":64},"Studies link SNHG18 expression to prognosis in different cancers, supporting its potential as a biomarker for diagnosis and treatment.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},345749,1790192679,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":115,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","BioMed Research International  \nThe Oncogenic and Tumor-Suppressive Roles of SNHG18: A Double-Edged Long Noncoding RNA in Cancer  \nVida Dehghani Champiri1 | Samira Asgharzade2  \n1Department of Student Research Committee, Shahrekord University of Medical Science, Shahrekord, Iran | 2Department of Cellular and Molecular  \nResearch Center, Basic Health Science Institute, Shahrekord University of Medical Science, Shahrekord, Iran Correspondence: Samira Asgharzade ([asgharzade1396@gmail.com](asgharzade1396@gmail.com))  \nReceived: 16 August 2025 | Revised: 7 June 2026 | Accepted: 17 June 2026  \nAcademic Editor: Poorani Gurumallesh Prabu  \nKeywords: cancer | lncRNAs | SNHG18  \nABSTRACT  \nNumerous recent studies have shown that long noncoding RNAs (lncRNAs) play a crucial role in the development of diverse cancers. Small nucleolar RNA host gene 18 (SNHG18) is a cancer-related lncRNA in the SNHG family, whose expression is dysregulated in various tumors and acts as either an oncogenic or tumor-suppressive factor. Several studies have demonstrated that SNHG18 exhibits dual effects in various cancers. The role of this molecule is context-dependent, acting as a tumor suppressor in certain cancers while exhibiting oncogenic properties in others. The expression of SNHG18 is cancer-type specific: it is upregulated in glioma, multiple myeloma, and lung cancer, but downregulated in bladder and hepatocellular cancer. Clinical studies have also found a correlation between SNHG18 expression and prognosis in different cancers. We present an overview of studies on SNHG18, emphasizing its biological functions and its potential as a promising biomarker for the diagnosis and treatment of diverse cancer types.  \n1 | Introduction  \nMore than 200 different types of cancer are recognized [1] . Cancer arises from the combined effects of genetic alterations—such as mutations—and epigenetic changes. Factors that affect the incidence and progression of cancer have been linked to protein-encoding regions, as 80% of the human genome is transcribed into RNA, and the majority of this RNA is noncoding [2–4] .  \nThere are two groups of RNAs: coding and noncoding RNAs (ncRNAs) . ncRNAs, which do not encode proteins, include a diverse range of molecules such as ribosomal RNAs (rRNAs), transfer RNAs (tRNAs), microRNAs (miRNAs), long noncoding RNAs (lncRNAs), small nuclear RNAs (snRNAs), and small nucleolar RNAs (snoRNAs) [5] . LncRNAs are a heterogeneous group typically defined as transcripts longer than 200 nucleotides, accounting for over half of the noncoding RNA in  \nmammals. They take part in various biological processes, such as transcriptional gene modulation, conservation of genomic unity, inactivation of the X chromosome, genomic imprinting, cell differentiation, and progression. LncRNAs have gained much attention in the community because of their role in cell proliferation, transformation, and tumorigenesis in different cancer signaling and cancer phenotypes. Accumulating evidence suggests that lncRNAs have modulated expression and may act as regulators of coding genes in the development of various cancers [6–9] .  \nSNHGs, as a small nucleolar RNA host gene, contain introns and exons, and the intron regions are converted into snoRNAs. SNHGs can regulate DNA methylation, transcription, and translation in cells [5, 10] . SNHGs have been described tobe upregulated in various cancers and may influence cell proliferation, apoptosis, invasion, migration, drug resistance, and other cancerous functions. Molecularly, SNHGs are competing  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \nCopyright © 2026 Vida Dehghani Champiri and Samira Asgharzade. BioMed Research International published by John Wiley & Sons Ltd.  \nBioMed Research International, 2026; 2026:9651227 1 of 9  \n[https://doi.org/10.1155/bmri/9651227](htt","cbCaitR2H1yVUOkK","https://ap.wps.com/l/cbCaitR2H1yVUOkK","pdf",450015,"English","# Introduction\n## Long noncoding RNAs and cancer biology\n## SNHGs and SNHG18 overview\n# Materials and Methods\n# Function of SNHG18 as an Oncogene in Human Cancers\n## Nonsmall Cell Lung Cancer (NSCLC)","[{\"question\":\"What role does SNHG18 play in cancer?\",\"answer\":\"SNHG18 acts as a dual-edge lncRNA, functioning as either an oncogene or a tumor suppressor depending on the cancer context.\"},{\"question\":\"How is SNHG18 expression different across cancer types?\",\"answer\":\"SNHG18 is upregulated in glioma, multiple myeloma, and lung cancer, while it is downregulated in bladder and hepatocellular cancer.\"},{\"question\":\"Why is SNHG18 considered important for clinical use?\",\"answer\":\"Studies link SNHG18 expression to prognosis in different cancers, supporting its potential as a biomarker for diagnosis and treatment.\"}]","The Oncogenic and Tumor-Suppressive Roles of SNHG18: A Double-Edged Long Noncoding RNA in Cancer | PDF",1790058777,23,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/62dc80b2a01673b3e067c6ac39b275aa.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/63b8d5f82e0c2794b39200319a0c1493.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7d5e0dc9ac47d45e42008009d9e6577c.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/39587a6261d78563869d24163fe36761.webp",980,1287]